212 related articles for article (PubMed ID: 10556673)
1. The assessment of antagonist potency under conditions of transient response kinetics.
Christopoulos A; Parsons AM; Lew MJ; El-Fakahany EE
Eur J Pharmacol; 1999 Oct; 382(3):217-27. PubMed ID: 10556673
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor.
Christopoulos A; Parsons AM; El-Fakahany EE
J Pharmacol Exp Ther; 1999 Jun; 289(3):1220-8. PubMed ID: 10336509
[TBL] [Abstract][Full Text] [Related]
3. Functional partial agonism at cloned human muscarinic acetylcholine receptors.
Bräuner-Osborne H; Ebert B; Brann MR; Falch E; Krogsgaard-Larsen P
Eur J Pharmacol; 1996 Oct; 313(1-2):145-50. PubMed ID: 8905341
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for the heterogeneity of functional muscarinic receptors in guinea pig gallbladder.
Akici A; Karaalp A; Iskender E; Christopoulos A; El-Fakahany EE; Oktay S
Eur J Pharmacol; 2000 Jan; 388(1):115-23. PubMed ID: 10657554
[TBL] [Abstract][Full Text] [Related]
5. Novel persistent activation of muscarinic M1 receptors by xanomeline.
Christopoulos A; El-Fakahany EE
Eur J Pharmacol; 1997 Sep; 334(1):R3-4. PubMed ID: 9346340
[TBL] [Abstract][Full Text] [Related]
6. Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor.
Grant MK; El-Fakahany EE
J Pharmacol Exp Ther; 2005 Oct; 315(1):313-9. PubMed ID: 16002459
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
Kenakin T; Boselli C
J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
[TBL] [Abstract][Full Text] [Related]
8. On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
Christopoulos A; Pierce TL; Sorman JL; El-Fakahany EE
Mol Pharmacol; 1998 Jun; 53(6):1120-30. PubMed ID: 9614217
[TBL] [Abstract][Full Text] [Related]
9. Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor.
De Lorme KC; Sikorski KL; Grant MK; El-Fakahany EE
Neurosci Lett; 2006 Dec; 410(1):11-4. PubMed ID: 17052840
[TBL] [Abstract][Full Text] [Related]
10. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM
Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068
[TBL] [Abstract][Full Text] [Related]
11. Equilibrium and kinetic measurements of muscarinic receptor antagonism on living cells using bead injection spectroscopy.
Hodder PS; Beeson C; Ruzicka J
Anal Chem; 2000 Jul; 72(14):3109-15. PubMed ID: 10939374
[TBL] [Abstract][Full Text] [Related]
12. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese Hamster Ovary cells.
Bradley KN; Rowan EG; Harvey AL
Toxicon; 2003 Feb; 41(2):207-15. PubMed ID: 12565740
[TBL] [Abstract][Full Text] [Related]
13. Activation of muscarinic acetylcholine receptors elicits pigment granule dispersion in retinal pigment epithelium isolated from bluegill.
González A; Crittenden EL; García DM
BMC Neurosci; 2004 Jul; 5():23. PubMed ID: 15251036
[TBL] [Abstract][Full Text] [Related]
14. Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.
Kukkonen JP; Näsman J; Rinken A; Dementjev A; Akerman KE
Biochem Biophys Res Commun; 1998 Feb; 243(1):41-6. PubMed ID: 9473476
[TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.
Jakubík J; Tucek S; El-Fakahany EE
J Pharmacol Exp Ther; 2002 Jun; 301(3):1033-41. PubMed ID: 12023535
[TBL] [Abstract][Full Text] [Related]
16. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
Forray C; el-Fakahany EE
Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells.
Casanova M; Furlán C; Sterin-Borda L; Borda ES
Auton Autacoid Pharmacol; 2006 Jul; 26(3):293-301. PubMed ID: 16879495
[TBL] [Abstract][Full Text] [Related]
18. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
Jakubík J; El-Fakahany EE; Dolezal V
Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
[TBL] [Abstract][Full Text] [Related]
19. Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.
Huang XP; Nagy PI; Williams FE; Peseckis SM; Messer WS
Br J Pharmacol; 1999 Feb; 126(3):735-45. PubMed ID: 10188986
[TBL] [Abstract][Full Text] [Related]
20. Role of M1 receptor in regulation of gastric fundus smooth muscle contraction.
Gajdus M; Szadujkis-Szadurska K; Szadujkis-Szadurski L; Glaza I; Szadujkis-Szadurski R; Olkowska J
Postepy Hig Med Dosw (Online); 2011 Sep; 65():584-7. PubMed ID: 21918262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]